Pluri Inc (PLUR)
5.84
+0.47
(+8.75%)
USD |
NASDAQ |
May 02, 16:00
5.84
0.00 (0.00%)
After-Hours: 20:00
Pluri Enterprise Value: 24.07M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 24.07M |
April 30, 2024 | 25.27M |
April 29, 2024 | 23.55M |
April 26, 2024 | 24.00M |
April 25, 2024 | 21.61M |
April 24, 2024 | 22.60M |
April 23, 2024 | 22.13M |
April 22, 2024 | 22.19M |
April 19, 2024 | 23.44M |
April 18, 2024 | 22.40M |
April 17, 2024 | 23.02M |
April 16, 2024 | 25.85M |
April 15, 2024 | 25.64M |
April 12, 2024 | 26.05M |
April 11, 2024 | 26.32M |
April 10, 2024 | 27.15M |
April 09, 2024 | 25.69M |
April 08, 2024 | 25.27M |
April 05, 2024 | 24.70M |
April 04, 2024 | 22.13M |
April 03, 2024 | 23.44M |
April 02, 2024 | 26.05M |
April 01, 2024 | 27.10M |
March 28, 2024 | 29.70M |
March 27, 2024 | 32.49M |
Date | Value |
---|---|
March 26, 2024 | 38.31M |
March 25, 2024 | 34.70M |
March 22, 2024 | 35.40M |
March 21, 2024 | 34.99M |
March 20, 2024 | 35.82M |
March 19, 2024 | 35.20M |
March 18, 2024 | 35.20M |
March 15, 2024 | 37.36M |
March 14, 2024 | 34.99M |
March 13, 2024 | 36.01M |
March 12, 2024 | 35.82M |
March 11, 2024 | 36.18M |
March 08, 2024 | 37.89M |
March 07, 2024 | 35.90M |
March 06, 2024 | 37.48M |
March 05, 2024 | 32.46M |
March 04, 2024 | 30.84M |
March 01, 2024 | 29.18M |
February 29, 2024 | 29.59M |
February 28, 2024 | 28.73M |
February 27, 2024 | 27.93M |
February 26, 2024 | 26.53M |
February 23, 2024 | 27.01M |
February 22, 2024 | 26.16M |
February 21, 2024 | 26.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.336M
Minimum
Sep 26 2022
253.32M
Maximum
Dec 08 2020
61.28M
Average
35.81M
Median
Enterprise Value Benchmarks
InspireMD Inc | 6.802M |
Taro Pharmaceutical Industries Ltd | 691.00M |
BiomX Inc | 20.83M |
Alpha Tau Medical Ltd | 91.03M |
Raphael Pharmaceutical Inc | 18.43M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -4.905M |
Revenue (Quarterly) | 0.105M |
Total Expenses (Quarterly) | 5.318M |
EPS Diluted (Quarterly) | -0.96 |
Profit Margin (Quarterly) | -4.67K% |
Earnings Yield | -79.45% |
Normalized Earnings Yield | -79.45 |